Top Markets
Coin of the day
Stella Diagnostics Inc. Stella Diagnostics Inc.

Stella Diagnostics Inc.

SLDX
Rank in Stocks #38821
Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on... Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on advancing patient care strategies for individuals afflicted with severe esophageal disorders. The company's specialized clinical tests furnish physicians with crucial information regarding the molecular makeup of a patient's tissue, enabling them to ascertain if the disease is static, deteriorating, or undergoing malignant transformation. Additionally, Stella Diagnostics is engaged in the development of innovative diagnostic tools intended to provide healthcare professionals with enhanced molecular insights compared to conventional screening methods. The organization rebranded from its previous identity, JMP Properties, Inc., to Stella Diagnostics, Inc. in April 2021 and is based in Salt Lake City, Utah.
Share Price
$0.00806
Last synced: 2026-08-13
Market Cap
$786.26K
Change (1 day)
0.00%
Change (1 year)
-73.13%
Country
US
Trade Stella Diagnostics Inc. (SLDX)

Category

P/B ratio for Stella Diagnostics Inc. (SLDX)
P/B ratio as of 2026 TTM: 0
According to Stella Diagnostics Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Stella Diagnostics Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
4.0441 -
US
2.6166 -
US
- -
CN
21.3575 -
US
28.7765 -
US